Ambulatory blood pressure monitoring phenotypes among individuals with and without diabetes taking antihypertensive medication: The Jackson Heart Study

Journal of Human Hypertension

Volumn 30, Issue 12, 2016, Pages 731-736

  Bromfield, S G ^a   Shimbo, D ^b   Bertoni, A G ^c   Sims, M ^d   Carson, A P ^a   Muntner, P ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Department of Medicine   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AFRICAN AMERICAN; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL PROTOCOL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; HUMAN; HYPERTENSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; MASKED ISOLATED NOCTURNAL HYPERTENSION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PREVALENCE; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION; AGED; BLOOD; BLOOD PRESSURE; CIRCADIAN RHYTHM; CLINICAL TRIAL; DRUG EFFECTS; EPIDEMIOLOGY; ETHNOLOGY; GLUCOSE BLOOD LEVEL; METABOLISM; MISSISSIPPI; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

AFRICAN AMERICANS; AGED; ANTIHYPERTENSIVE AGENTS; BIOMARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MISSISSIPPI; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84966606319     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2016.27     Document Type: Article

References (34)

1. He J, Whelton PK. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertens Suppl 1999; 17: S7-S13.
2. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-18.
3. Hypertension in Diabetes Study Group. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993; 11: 309-317.
4. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49: 1379-1385.
5. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 2006; 354: 2368-2374.
6. O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013; 31: 1731-1768.
7. Turner JR, Viera AJ, Shimbo D. Ambulatory blood pressure monitoring in clinical practice: a review. Am J Med 2014; 128(1): 14-20.
8. Mancia G, Bombelli M, Seravalle G, Grassi G. Diagnosis and management of patients with white-coat and masked hypertension. Nat Rev Cardiol 2011; 8: 686-693.
9. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20: 2183-2189.
10. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107: 1401-1406.
11. Gorostidi M, de la Sierra A, González-Albarrán O, Segura J, de la Cruz JJ, Vinyoles E et al. Abnormalities in ambulatory blood pressure monitoring in hypertensive patients with diabetes. Hypertens Res 2011; 34: 1185-1189.
12. Taylor HA, Wilson JG, Jones DW, Sarpong DF, Srinivasan A, Garrison RJ et al. Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. Ethn Dis 2005; 15: S6-4-17.
13. Carpenter MA, Crow R, Steffes M, Rock W, Heilbraun J, Evans G et al. Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study. Am J Med Sci 2004; 328: 131-144.
14. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936-942.
15. Dubbert PM, Carithers T, Ainsworth BE, Taylor HA, Wilson G, Wyatt SB. Physical activity assessment methods in the Jackson Heart Study. Ethn Dis 2005; 15: S6-56-61.
16. Thijs L, Hansen TW, Kikuya M, Björklund-Bodegard K, Li Y, Dolan E et al. The International Database of Ambulatory Blood Pressure in relation to Cardiovascular Outcome (IDACO): protocol and research perspectives. Blood Press Monit 2007; 12: 255-262.
17. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1925-1938.
18. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011; 30: 377-399.
19. Pierdomenico SD, Lapenna D, Di Mascio R, Cuccurullo F. Short-And long-term risk of cardiovascular events in white-coat hypertension. J Hum Hypertens 2008; 22: 408-414.
20. Franklin SS, Thijs L, Li Y, Hansen TW, Boggia J, Liu Y et al. Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension 2013; 61: 964-971.
21. Profant J, Dimsdale JE. Race and diurnal blood pressure patterns. A review and meta-Analysis. Hypertension 1999; 33: 1099-1104.
22. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 2000; 283: 2253-2259.
23. Muntner P, Lewis CE, Diaz KM, Carson AP, Kim Y, Calhoun D et al. Racial differences in abnormal ambulatory blood pressure monitoring measures: results from the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Hypertens 2014; 28(5): 640-648.
24. Viera AJ, Zhu S, Hinderliter AL, Shimbo D, Person SD, Jacobs DR. Diurnal blood pressure pattern and development of prehypertension or hypertension in young adults: the CARDIA study. J Am Soc Hypertens 2010; 5: 48-55.
25. Hermida RC, Ayala DE, Mojón A, Fernández JR. Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes. Am J Hypertens 2012; 25: 325-334.
26. Salles GF, Leite NC, Pereira BB, Nascimento EM, Cardoso CRL. Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study. J Hypertens 2013; 31: 2176-2186.
27. National Clinical Guideline Centre. Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34 [Internet]. NICE Clinical Guidelines, No. 127. Royal College of Physicians: London, UK, 2011.
28. Siu AL. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2015; 163: 778-786.
29. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion J-M, Mancia G et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21: 821-848.
30. Pogue V, Rahman M, Lipkowitz M, Toto R, Miller E, Faulkner M et al. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension 2009; 53: 20-27.
31. Maciejewski S, Mohiuddin SM, Packard KA, Mooss AN, Reyes AP, Aryana A et al. Randomized, double-blind, crossover comparison of amlodipine and valsartan in african-Americans with hypertension using 24-hour ambulatory blood pressure monitoring. Pharmacotherapy 2006; 26: 889-895.
32. Barnes VA, Treiber FA, Johnson MH. Impact of transcendental meditation on ambulatory blood pressure in African-American adolescents. Am J Hypertens 2004; 17: 366-369.
33. Kuznik A, Mardekian J. Trends in utilization of lipid-And blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008. Cardiovasc Diabetol 2011; 10: 31.
34. Wong HK, Ong KL, Cheung C-L, Cheung BMY. Utilization of glucose, blood pressure, and lipid lowering medications among people with type II diabetes in the United States, 1999-2010. Ann Epidemiol 2014; 24: 516-521.